Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
For a patient presenting with hyperglycaemia in primary care, the recommended initial investigations include:
- Confirming hyperglycaemia diagnosis: Measure blood glucose levels, preferably plasma glucose, as patient-held glucose meters are calibrated to plasma glucose equivalents NICE NG17,NICE NG18.
- Assess diabetes subtype: In adults, make an initial clinical diagnosis of type 1 diabetes considering features such as ketosis, rapid weight loss, age under 50 years, BMI below 25 kg/m2, and personal or family history of autoimmune disease, but do not rely on age or BMI alone NICE NG17.
- Diabetes-specific autoantibodies: Measure diabetes-specific autoantibodies in adults with suspected type 1 diabetes at initial diagnosis to support classification, ideally quantitative tests for at least two different autoantibodies NICE NG17.
- Serum C-peptide: Do not routinely measure serum C-peptide at initial diagnosis; consider it only if autoantibody results are negative and diabetes classification remains uncertain NICE NG17.
- HbA1c measurement: Measure HbA1c to assess average blood glucose control over the preceding 2–3 months and to support diagnosis and management planning NICE CKS,NICE CKS.
- Urine albumin:creatinine ratio (ACR) and serum creatinine: Assess kidney function and detect proteinuria as part of baseline evaluation, especially in type 1 diabetes, to identify risk of diabetic kidney disease NICE CKS,NICE CKS.
Key References
- NG17 - Type 1 diabetes in adults: diagnosis and management
- NG18 - Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- PH38 - Type 2 diabetes: prevention in people at high risk
- NG3 - Diabetes in pregnancy: management from preconception to the postnatal period
- CKS - Diabetes - type 1
- CKS - Type 1 diabetes